Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19698 | 493 | 27.4 | 52% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
154 | 3 | PSYCHIATRY//ALEXITHYMIA//PSYCHIAT | 62481 |
207 | 2 | PSYCHIATRY//ANTIDEPRESSANTS//DEPRESSION | 21074 |
19698 | 1 | TRAZODONE//NEFAZODONE//ETOPERIDONE | 493 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRAZODONE | authKW | 987813 | 13% | 26% | 62 |
2 | NEFAZODONE | authKW | 758357 | 9% | 28% | 43 |
3 | ETOPERIDONE | authKW | 185810 | 1% | 100% | 3 |
4 | M CHLOROPHENYLPIPERAZINE | authKW | 183341 | 3% | 20% | 15 |
5 | HYDROXYNEFAZODONE | authKW | 123874 | 0% | 100% | 2 |
6 | NEFAZODONE HYDROCHLORIDE | authKW | 123874 | 0% | 100% | 2 |
7 | RENAL IMPAIRMENT PHARMACOKINETICS | authKW | 82581 | 0% | 67% | 2 |
8 | TRAZODONE HYDROCHLORIDE | authKW | 76224 | 1% | 31% | 4 |
9 | 1 ARYL PIPERAZINES | authKW | 61937 | 0% | 100% | 1 |
10 | 13 TRIFLUOROMETHYLPHENYLPIPERAZINE TFMPP | authKW | 61937 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 4677 | 35% | 0% | 174 |
2 | Pharmacology & Pharmacy | 4059 | 53% | 0% | 260 |
3 | Psychology, Clinical | 250 | 5% | 0% | 27 |
4 | Chemistry, Analytical | 208 | 10% | 0% | 50 |
5 | Toxicology | 170 | 6% | 0% | 31 |
6 | Neurosciences | 146 | 12% | 0% | 61 |
7 | Clinical Neurology | 69 | 7% | 0% | 33 |
8 | Medicine, General & Internal | 58 | 7% | 0% | 33 |
9 | Medicine, Legal | 53 | 1% | 0% | 6 |
10 | Medicine, Research & Experimental | 25 | 4% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | 5 PKWY | 61937 | 0% | 100% | 1 |
2 | AUSTRALASIA QUAL ASSURANCE PROGRAMS | 61937 | 0% | 100% | 1 |
3 | BEHAV HLTH BUR | 61937 | 0% | 100% | 1 |
4 | EMPLOYEE BEHAV HLTH DARTMOUTH | 61937 | 0% | 100% | 1 |
5 | GRP RECH ANALYSE MOUVEMENT ETERGON | 61937 | 0% | 100% | 1 |
6 | HERTFORDSHIRE NEUROSCI GRP | 61937 | 0% | 100% | 1 |
7 | LOCAL HLTH UNIT 4TH | 61937 | 0% | 100% | 1 |
8 | MENTAL HLTH HEBEI PROV | 61937 | 0% | 100% | 1 |
9 | MENZIES HLTH QUEENSLANDS | 61937 | 0% | 100% | 1 |
10 | METAB PHARMACOKINET PHARMACEUT | 61937 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOPSYCHIATRIA | 13113 | 1% | 4% | 5 |
2 | PSYCHOPATHOLOGY | 11002 | 3% | 1% | 17 |
3 | INTERNATIONAL PHARMACOPSYCHIATRY | 9084 | 1% | 4% | 4 |
4 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 6596 | 3% | 1% | 17 |
5 | JOURNAL OF CLINICAL PSYCHIATRY | 6350 | 5% | 0% | 27 |
6 | POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY | 5092 | 2% | 1% | 8 |
7 | CLINICAL NEUROPHARMACOLOGY | 2573 | 2% | 0% | 10 |
8 | PHARMACOPSYCHIATRY | 1965 | 2% | 0% | 8 |
9 | PSYCHOPHARMACOLOGY BULLETIN | 1684 | 1% | 0% | 7 |
10 | NEUROPSYCHOBIOLOGY | 1657 | 2% | 0% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRAZODONE | 987813 | 13% | 26% | 62 | Search TRAZODONE | Search TRAZODONE |
2 | NEFAZODONE | 758357 | 9% | 28% | 43 | Search NEFAZODONE | Search NEFAZODONE |
3 | ETOPERIDONE | 185810 | 1% | 100% | 3 | Search ETOPERIDONE | Search ETOPERIDONE |
4 | M CHLOROPHENYLPIPERAZINE | 183341 | 3% | 20% | 15 | Search M+CHLOROPHENYLPIPERAZINE | Search M+CHLOROPHENYLPIPERAZINE |
5 | HYDROXYNEFAZODONE | 123874 | 0% | 100% | 2 | Search HYDROXYNEFAZODONE | Search HYDROXYNEFAZODONE |
6 | NEFAZODONE HYDROCHLORIDE | 123874 | 0% | 100% | 2 | Search NEFAZODONE+HYDROCHLORIDE | Search NEFAZODONE+HYDROCHLORIDE |
7 | RENAL IMPAIRMENT PHARMACOKINETICS | 82581 | 0% | 67% | 2 | Search RENAL+IMPAIRMENT+PHARMACOKINETICS | Search RENAL+IMPAIRMENT+PHARMACOKINETICS |
8 | TRAZODONE HYDROCHLORIDE | 76224 | 1% | 31% | 4 | Search TRAZODONE+HYDROCHLORIDE | Search TRAZODONE+HYDROCHLORIDE |
9 | 1 ARYL PIPERAZINES | 61937 | 0% | 100% | 1 | Search 1+ARYL+PIPERAZINES | Search 1+ARYL+PIPERAZINES |
10 | 13 TRIFLUOROMETHYLPHENYLPIPERAZINE TFMPP | 61937 | 0% | 100% | 1 | Search 13+TRIFLUOROMETHYLPHENYLPIPERAZINE+TFMPP | Search 13+TRIFLUOROMETHYLPHENYLPIPERAZINE+TFMPP |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GREENE, DS , BARBHAIYA, RH , (1997) CLINICAL PHARMACOKINETICS OF NEFAZODONE.CLINICAL PHARMACOKINETICS. VOL. 33. ISSUE 4. P. 260-275 | 32 | 82% | 70 |
2 | DAVIS, R , WHITTINGTON, X , BRYSON, HM , (1997) NEFAZODONE - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN THE MANAGEMENT OF MAJOR DEPRESSION.DRUGS. VOL. 53. ISSUE 4. P. 608-636 | 40 | 52% | 108 |
3 | KARHU, D , GOSSEN, ER , MOSTERT, A , CRONJE, T , FRADETTE, C , (2011) SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ONCE-DAILY TRAZODONE EXTENDED-RELEASE CAPLETS IN HEALTHY SUBJECTS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 49. ISSUE 12. P. 730-743 | 22 | 71% | 7 |
4 | HARIA, M , FITTON, A , MCTAVISH, D , (1994) TRAZODONE - A REVIEW OF ITS PHARMACOLOGY, THERAPEUTIC USE IN DEPRESSION AND THERAPEUTIC POTENTIAL IN OTHER DISORDERS.DRUGS & AGING. VOL. 4. ISSUE 4. P. 331-355 | 53 | 45% | 89 |
5 | FAGIOLINI, A , COMANDINI, A , DELL'OSSO, MC , KASPER, S , (2012) REDISCOVERING TRAZODONE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER.CNS DRUGS. VOL. 26. ISSUE 12. P. 1033 -1049 | 35 | 39% | 24 |
6 | MARTINEZ, MA , BALLESTEROS, S , DE LA TORRE, CS , ALMARZA, E , (2005) INVESTIGATION OF A FATALITY DUE TO TRAZODONE POISONING: CASE REPORT AND LITERATURE REVIEW.JOURNAL OF ANALYTICAL TOXICOLOGY. VOL. 29. ISSUE 4. P. 262-268 | 25 | 68% | 13 |
7 | JAREMA, M , DUDEK, D , LANDOWSKI, J , HEITZMAN, J , RABE-JABLONSKA, J , RYBAKOWSKI, J , (2011) TRAZODON - THE ANTIDEPRESSANT: MECHANISM OF ACTION AND ITS POSITION IN THE TREATMENT OF DEPRESSION.PSYCHIATRIA POLSKA. VOL. 45. ISSUE 4. P. 611 -625 | 21 | 64% | 1 |
8 | MENDELSON, WB , (2005) A REVIEW OF THE EVIDENCE FOR THE EFFICACY AND SAFETY OF TRAZODONE IN INSOMNIA.JOURNAL OF CLINICAL PSYCHIATRY. VOL. 66. ISSUE 4. P. 469-476 | 22 | 52% | 110 |
9 | ROTZINGER, S , BAKER, GB , (2002) HUMAN CYP3A4 AND THE METABOLISM OF NEFAZODONE AND HYDROXYNEFAZODONE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED ENZYMES.EUROPEAN NEUROPSYCHOPHARMACOLOGY. VOL. 12. ISSUE 2. P. 91-100 | 24 | 56% | 15 |
10 | KHOUZAM, HR , (2017) A REVIEW OF TRAZODONE USE IN PSYCHIATRIC AND MEDICAL CONDITIONS.POSTGRADUATE MEDICINE. VOL. 129. ISSUE 1. P. 140 -148 | 25 | 37% | 0 |
Classes with closest relation at Level 1 |